LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) Form 10-K Annual Reports
LIFECORE BIOMEDICAL, INC. \DE\ (LFCR) is a publicly traded company on the Nasdaq, categorized under SIC 2834 (Pharmaceutical Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: LFCR
CIK: 1005286
Exchange: Nasdaq
SIC 2834: Pharmaceutical Preparations
Fiscal Year End: 05/25
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
KPMG LLP
Auditor SinceSince 12/31/2025 12:00:00 AM
Lead Engagement PartnerJohn Sasselli
Audit LocationPhiladelphia, Pennsylvania, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| SCHEDULE 13D/A | 2026-09-29 | — | SCHEDULE 13D/A Filing | 0001104659-26-111939 | View SEC Doc Filr Page |
| 8-K | 2026-09-29 | 2026-09-24 | 8-K | 0001005286-26-000036 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-09-28 | — | SCHEDULE 13D/A Filing | 0000921895-26-002661 | View SEC Doc Filr Page |
| DEFA14A | 2026-09-28 | — | DEFA 14A | 0001140361-26-037768 | View SEC Doc Filr Page |
| 8-K | 2026-09-28 | 2026-09-27 | 8-K | 0001140361-26-037767 | View SEC Doc Filr Page |
| 10-Q | 2026-08-05 | 2026-06-30 | 10-Q | 0001005286-26-000033 | View SEC Doc Filr Page |
| 8-K | 2026-08-05 | 2026-08-05 | 8-K | 0001005286-26-000032 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-07-29 | — | SCHEDULE 13G Filing | 0002012383-26-002896 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-02 | — | SCHEDULE 13D/A Filing | 0000921895-26-001747 | View SEC Doc Filr Page |
| 8-K | 2026-07-02 | 2026-06-29 | 8-K | 0001005286-26-000026 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-07-02 | — | SCHEDULE 13D/A Filing | 0001193125-26-294951 | View SEC Doc Filr Page |
| 4 | 2026-06-08 | 2026-06-04 | OWNERSHIP DOCUMENT | 0000921895-26-001575 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001017043-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001376960-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001336601-26-000004 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001649903-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001800145-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0002034858-26-000002 | View SEC Doc Filr Page |
| 4 | 2026-06-05 | 2026-06-04 | FORM 4 | 0001269294-26-000002 | View SEC Doc Filr Page |
| 8-K | 2026-06-05 | 2026-06-04 | 8-K | 0001005286-26-000023 | View SEC Doc Filr Page |
| 4 | 2026-05-21 | 2026-05-20 | FORM 4 | 0002022547-26-000003 | View SEC Doc Filr Page |
| 10-Q | 2026-05-06 | 2026-03-31 | 10-Q | 0001005286-26-000020 | View SEC Doc Filr Page |
| 8-K | 2026-05-06 | 2026-05-06 | 8-K | 0001005286-26-000018 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-04-27 | — | SCHEDULE 13G/A Filing | 0002012383-26-001749 | View SEC Doc Filr Page |
| DEF 14A | 2026-04-24 | 2026-04-24 | DEF 14A | 0001005286-26-000012 | View SEC Doc Filr Page |